Current report filing

Note 10 - Investment in Macrophage Therapeutics, Inc. (Details Textual)

v3.8.0.1
Note 10 - Investment in Macrophage Therapeutics, Inc. (Details Textual) - USD ($)
 1 Months Ended 6 Months Ended 12 Months Ended
Mar. 11, 2015
Mar. 31, 2015
May 31, 2016
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Preferred Stock, Shares Authorized       5,000,000 5,000,000  
Preferred Stock, Par or Stated Value Per Share       $ 0.001 $ 0.001  
Preferred Stock, Shares Issued       0 0  
Derivative Liability   $ 63,000   $ 63,000 $ 63,000  
Preferred Stock Dividends and Other Adjustments       46,000
Preferred Convertible Stock, Right to Exchange for Common Shares, Minimum Required Proceeds from Initial Public Offering         $ 50,000,000  
Weighted Average Price Common Stock Percentage         80.00%  
Future Common Stock Conversion Share Price         3.00%  
Dr. Michael Goldberg [Member]            
Convertible Preferred Stock, Percent of Shares Reserved   40.00%        
Dr. Michael Goldberg [Member] | MT [Member]            
Payments to Acquire Businesses and Interest in Affiliates   $ 200,000        
Macrophage Therapeutics [Member]            
Common Stock Shares Authorized Upon Exercise of Warrants   1,500        
Convertible Preferred Stock Shares Issued Upon Conversion, Per Unit   1        
Common Stock Warrants, Issued Upon Conversion, Per Unit   30        
Macrophage Therapeutics [Member] | Common Stock [Member]            
Common Stock as Percentage of Common Equity   1.00%        
Class of Warrant or Right, Number of Securities Called by Warrants or Rights 300     300    
Platinum [Member] | MT [Member]            
Payments to Acquire Businesses and Interest in Affiliates   $ 300,000 $ 200,000      
MT [Member]            
Convertible Preferred Stock, PIK Coupon, Percentage     10.00%      
Convertible Preferred Stock, Conversion Price, Market Cap     $ 500,000,000      
Convertible Preferred Stock [Member]            
Preferred Stock, Shares Authorized   50        
Preferred Stock, Par or Stated Value Per Share   $ 50,000        
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants $ 500,000          
Issuance of Stock and Warrants for Purchase Agreement, Remaining Amount         $ 2,000,000  
Preferred Stock, Fair Value Put Option         113,000  
Future Common Stock Conversion Denominator, Value         50,000  
Convertible Preferred Stock [Member] | Macrophage Therapeutics [Member]            
Preferred Stock, Shares Authorized   50        
Preferred Stock, Shares Issued   10        
Preferred Stock Dividends and Other Adjustments   $ 46,000     $ 46,000  
Preferred Stock, Redemption Price Per Share         $ 58,320